From Casetext: Smarter Legal Research

Sumitomo Pharma Co. v. Vidal

United States Court of Appeals, Federal Circuit
May 28, 2024
No. 2022-2276 (Fed. Cir. May. 28, 2024)

Opinion

2022-2276

05-28-2024

SUMITOMO PHARMA CO., LTD., Appellant v. KATHERINE K. VIDAL, UNDER SECRETARY OF COMMERCE FOR INTELLECTUAL PROPERTY AND DIRECTOR OF THE UNITED STATES PATENT AND TRADEMARK OFFICE, Intervenor


Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2020-01053.

MANDATE

In accordance with the judgment of this Court, entered April 5, 2024, and pursuant to Rule 41 of the Federal Rules of Appellate Procedure, the formal mandate is hereby issued.


Summaries of

Sumitomo Pharma Co. v. Vidal

United States Court of Appeals, Federal Circuit
May 28, 2024
No. 2022-2276 (Fed. Cir. May. 28, 2024)
Case details for

Sumitomo Pharma Co. v. Vidal

Case Details

Full title:SUMITOMO PHARMA CO., LTD., Appellant v. KATHERINE K. VIDAL, UNDER…

Court:United States Court of Appeals, Federal Circuit

Date published: May 28, 2024

Citations

No. 2022-2276 (Fed. Cir. May. 28, 2024)